Subscribe To Our Free Newsletter |
Biocon sheds 4%, hits 52-week low as US FDA issues form 483 for 3 sites
The US health regulator has issued Form 483s with 11 observations each for two sites in Bengaluru and six observations for a plant in Malaysia site.